Clinical Trials Logo

PAIS clinical trials

View clinical trials related to PAIS.

Filter by:
  • None
  • Page 1

NCT ID: NCT03171818 Recruiting - Perinatal Stroke Clinical Trials

Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration

DINOSAUR
Start date: July 1, 2017
Phase: Phase 2
Study type: Interventional

The aim of the study is to perform a randomized double-blind placebo controlled prospective study in newborn infants with MRI confirmed Middle Cerebral Artery (MCA) Perinatal Arterial Ischemic Stroke (PAIS) with darbepoetin. It will be investigated whether intravenous administered darbepoetin can induce the formation of neuronal tissue and restore brain function in neonates who suffered from PAIS compared to placebo treated controls. The ultimate goal of this study is therefore to develop a therapy using erythropoiesis-stimulating agents (ESA) such as darbepoetin to reduce or even prevent lifelong consequences of PAIS-related brain injury in this group of term newborns.